We invest across public and private markets in companies transforming biological insight into measurable health outcomes.
Vital Equities Ventures is a healthcare and life sciences investment firm identifying exceptional companies at every stage of development.
We combine deep scientific analysis with an entrepreneurial perspective, investing where rigorous understanding of biology and medicine reveals asymmetric opportunity. Our approach spans the full spectrum — from early-stage venture through public equities — allowing us to support innovation wherever it creates the greatest value.
Novel mechanisms and modalities addressing significant unmet need. Small molecules, biologics, gene and cell therapy, and RNA-based approaches with clear clinical differentiation.
Technologies transforming disease detection and measurement. Liquid biopsy, companion diagnostics, point-of-care platforms, and precision medicine infrastructure.
Platforms reshaping care delivery and access. Clinical AI, digital health, autonomous medical systems, and enabling technology for the modern healthcare ecosystem.
Foundational platforms powering discovery. Computational biology, synthetic biology, advanced imaging, and data-driven drug development tools.
Every thesis starts with the biology. We evaluate mechanism of action, clinical evidence, trial design, and competitive landscape through independent analysis — consulting primary literature and domain experts.
Healthcare value materializes at discrete inflection points. We identify and map catalysts — clinical readouts, regulatory milestones, commercial events — and position capital around probability-weighted outcomes.
We prefer depth over breadth. Fewer, higher-conviction positions allow us to understand our companies with the intimacy required for informed decision-making through complex development cycles.
Biology operates on its own timeline. We are long-term partners willing to support innovation through the full arc of development when our scientific conviction remains intact.
Serial entrepreneur and investor with three decades building and scaling companies across technology, telecommunications, and healthcare. Founded Viatel, Jazztel, Ya.com, FON, Prelude Fertility, Gameto, and Overture. Brings a founder's perspective to healthcare investing — an understanding that transformative companies emerge at the intersection of scientific breakthrough and market need.
Physician and healthcare investor bridging clinical medicine and capital markets. Medical degree with advanced training in internal medicine, combined with an MBA focused on healthcare management. Evaluates every opportunity through the lens of clinical practice — understanding not only whether the science works, but whether it will fundamentally change how medicine is practiced.